3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Breast Neoplasms
3
Zollinger-Ellison Syndrome
2
Gastroesophageal Reflux
2
Barrett Esophagus
2
Xerostomia
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Stomach Ulcer
1
Stomach Neoplasms
1
Pseudomyxoma Peritonei
1
Oropharyngeal Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Endocrine Neoplasia
1
Mucositis
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, B-Cell
1
Hemorrhage
1
Heartburn
1
Head and Neck Neoplasms
1
Esophagitis, Peptic
1
Endometrial Neoplasms
1
Carcinoma, Neuroendocrine
1
Carcinoid Tumor
1
Appendiceal Neoplasms
1
Interventions
Paclitaxel
13
pembrolizumab
8
Carboplatin
7
Cisplatin
5
Docetaxel
4
Brachytherapy
4
Pemetrexed
3
Gemcitabine
3
Doxorubicin
3
Biopsy
3
osimertinib
2
olaparib
2
niraparib
2
durvalumab
2
adavosertib
2
Trastuzumab
2
Topotecan
2
Taxes
2
Standard of Care
2
Sentinel Lymph Node Biopsy
2
Saline Solution
2
Radiotherapy
2
Radiation
2
Oxaliplatin
2
Nivolumab
2
Music Therapy
2
Magnetic Resonance Spectroscopy
2
Leucovorin
2
Letrozole
2
Immunoglobulin G
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Uterine Neoplasms
×
Lansoprazole
×
Clear all
NCT03192059
2021-09-08
PRIMMO
University Hospital, Ghent
Phase 2
Completed
43 enrolled